Literature DB >> 27220685

Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill.

Peter Reuter1, Bryce Pardo2.   

Abstract

The regulation of new psychoactive substances (NPS) has confounded governments throughout the western world. In 2014 the UK government convened an NPS Review Expert Panel to consider a range of approaches. Ultimately the Panel recommended that the government ban all new psychoactive drugs and allow only psychoactive substances specifically exempted, such as alcohol, tobacco and those allowed as medicines. The government introduced the Psychoactive Substances Bill (PSB) in response to that recommendation. Passed in 2016, the Bill has attracted a torrent of criticism from scientists and experts. The Bill could be improved with revision, but the problems of the total ban, as envisioned by the PSB, with respect to the NPS, may be inherent: (1) defining psychoactivity is conceptually fraught, with great consequence for the scope of the prohibition; (2) operationalizing psychoactivity as a usable concept for legal control purposes is extremely difficult, perhaps impossible; and (3) the detachment of penalties for violating a total ban from establishing the harmfulness of a substance is normatively troubling. Given the uncertainties about the effects of a total ban, it is appropriate at this time for other governments to assess more fully the nature of the NPS problem, and the potential control approaches.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  Headshops; Psychoactive Substances Act; legal highs; new psychoactive substances; psychoactivity; regulation; substitution effect

Mesh:

Substances:

Year:  2016        PMID: 27220685     DOI: 10.1111/add.13439

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

Review 1.  Understanding the UK Psychoactive Substances Act.

Authors:  Raymond G Hill
Journal:  Br J Clin Pharmacol       Date:  2020-01-03       Impact factor: 4.335

2.  Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries.

Authors:  Marie Claire Van Hout; Annemieke Benschop; Michal Bujalski; Katarzyna Dąbrowska; Zsolt Demetrovics; Katalin Felvinczi; Evelyn Hearne; Susana Henriques; Zsuzsa Kaló; Gerrit Kamphausen; Dirk Korf; Joana Paula Silva; Łukasz Wieczorek; Bernd Werse
Journal:  Int J Ment Health Addict       Date:  2017-12-07       Impact factor: 3.836

3.  The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study.

Authors:  Ornella Corazza; Pierluigi Simonato; Zsolt Demetrovics; Roisin Mooney; Katinka van de Ven; Andres Roman-Urrestarazu; Lili Rácmolnár; Ilaria De Luca; Eduardo Cinosi; Rita Santacroce; Massimo Marini; David Wellsted; Keith Sullivan; Giuseppe Bersani; Giovanni Martinotti
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

Review 4.  New psychoactive substances: a review and updates.

Authors:  Abu Shafi; Alex J Berry; Harry Sumnall; David M Wood; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2020-12-17

5.  Physical Activity and Exercise Addiction During the Covid-19 Pandemic in Italy.

Authors:  Franca Ceci; Francesco Di Carlo; Julius Burkauskas; Anatolia Salone; Ilaria De Luca; Dorotea Cicconcelli; Valentina Giorgetti; Irene La Fratta; Antonino Todaro; Pierluigi Simonato; Giovanni Martinotti; Massimo di Giannantonio; Ornella Corazza
Journal:  Int J Ment Health Addict       Date:  2022-04-20       Impact factor: 11.555

6.  Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.

Authors:  Adrian A Deen; Hugh Claridge; Richard D Treble; Hilary J Hamnett; Caroline S Copeland
Journal:  J Psychopharmacol       Date:  2021-06-29       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.